Innate Pharma SA
1.5940
19-September-25 08:27:32
15 minutes delayed
Stocks
-0.0810
-4.84%
Today's range
1.5720 - 1.7070
ISIN
FR0010331421
Source
Cboe
-
Innate Pharma to Hold its Annual General Meeting of Shareholders on May 28, 2021
20 Apr 2021 22:00:00 By Nasdaq GlobeNewswire
-
NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF APRIL 1, 2021
18 Apr 2021 22:00:00 By Nasdaq GlobeNewswire
-
Innate Pharma reports Full Year 2020 financial results and business update
17 Mar 2021 23:00:00 By Nasdaq GlobeNewswire
-
Innate Pharma announces conference call and webcast for Full Year 2020 financial results
15 Mar 2021 23:00:00 By Nasdaq GlobeNewswire
-
Number of shares and voting rights of Innate Pharma as of February 1, 2021
23 Feb 2021 22:00:00 By Nasdaq GlobeNewswire
-
Innate Pharma to participate in the 10th Annual SVB Leerink Global Healthcare Conference
16 Feb 2021 22:00:00 By Nasdaq GlobeNewswire
-
Innate Pharma advances lacutamab clinical development program
08 Feb 2021 22:00:00 By Nasdaq GlobeNewswire
-
02 Feb 2021 22:00:00 By Nasdaq GlobeNewswire
-
Innate's first NK cell engager selected by Sanofi as drug candidate for development
04 Jan 2021 22:00:00 By Nasdaq GlobeNewswire
-
Innate Pharma to participate in upcoming investor conferences
03 Jan 2021 22:00:00 By Nasdaq GlobeNewswire